Erebouni Medical Center
Medical Journal Erebouni

QUTENZATM versus pregabalin in subjects with peripheral neuropathic pain: an open-label, randomized, multicenter, non-inferiority efficacy and tolerability study




Date - 2011-2012.

Participating Specialists - TA Stepanyan, Yeghiazaryan NS Kteyan AA

ID - NCT01713426

Type of clinical trial - intervention

Joint  participating organization: Astellas Pharma Europe Ltd. (

In accordance with the "Law of Copyright and Related Rights" when copying or reproduction of materials posted on this site, specify the source - the Web site of the Erebouni Medical Center - is highly requested.
Back to top